Applicant, as named in the Orange Book

Lantheus Medcl

Next listed expiry: Definity on 4 May 2037. 2 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Definity NDA 021064 perflutren	perflutren	4 May 2037 patent, carve-out possible	patent, carve-out possible
Definity Rt NDA 021064 perflutren	perflutren	4 May 2037 patent, carve-out possible	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.